A thermal analysis method to predict the complete phase diagram of drug-polymer solid dispersions.

The aim of this work was to develop a method which uses experimentally obtainable data to predict the complete phase diagram of drug-polymer solid dispersion systems, for the first time in literature. Felodipine-poly(acrylic acid) (PAA) solid dispersion was used as an example to illustrate the application of this method. Samples were prepared with different drug loading and analyzed using differential scanning calorimetry (DSC). Values of the drug-polymer interaction parameter χ(T(m)) were calculated from the drug crystal melting point depression data. Since χ is a function of temperature (χ∼1/T) according to the Flory-Huggins theory, the obtained χ-T relationship thus enabled calculation of the complete temperature-composition phase diagram of a drug-polymer solid dispersion system. In experiments, felodipine was shown to be immiscible with PAA in almost the whole range of drug content at room temperature. Two glass transition temperatures were observed, corresponding to almost pure felodipine and pure PAA, respectively, in consistent with the predicted phase behavior.

[1]  G. Van den Mooter,et al.  Review: physical chemistry of solid dispersions , 2009 .

[2]  Lian Yu,et al.  Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc. , 2010, Journal of pharmaceutical sciences.

[3]  Feng Qian,et al.  Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development. , 2010, Journal of pharmaceutical sciences.

[4]  Patrick J. Marsac,et al.  Theoretical and Practical Approaches for Prediction of Drug–Polymer Miscibility and Solubility , 2006, Pharmaceutical Research.

[5]  D. T. Friesen,et al.  Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. , 2008, Molecular pharmaceutics.

[6]  Allan S. Myerson,et al.  Solubility measurement using differential scanning calorimetry , 2002 .

[7]  Geert Verreck,et al.  Identification of Phase Separation in Solid Dispersions of Itraconazole and Eudragit® E100 Using Microthermal Analysis , 2004, Pharmaceutical Research.

[8]  B. Sarmento,et al.  Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. , 2007, Drug discovery today.

[9]  Evangelos Karavas,et al.  Miscibility Behavior and Formation Mechanism of Stabilized Felodipine-Polyvinylpyrrolidone Amorphous Solid Dispersions , 2005, Drug development and industrial pharmacy.

[10]  L Yu,et al.  Amorphous pharmaceutical solids: preparation, characterization and stabilization. , 2001, Advanced drug delivery reviews.

[11]  Stephen Z. D. Cheng.  Phase Transitions in Polymers: The Role of Metastable States , 2008 .

[12]  S. Riegelman,et al.  Pharmaceutical applications of solid dispersion systems. , 1971, Journal of pharmaceutical sciences.

[13]  A. Serajuddin,et al.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.

[14]  Patrick J. Marsac,et al.  Estimation of Drug–Polymer Miscibility and Solubility in Amorphous Solid Dispersions Using Experimentally Determined Interaction Parameters , 2008, Pharmaceutical Research.

[15]  H. Berghmans,et al.  Amorphous thermoreversible gebs of atadic polystyrene , 1987 .

[16]  R. Censi,et al.  Differences in the interaction between aryl propionic acid derivatives and poly(vinylpyrrolidone) K30: A multi-methodological approach. , 2009, Journal of pharmaceutical sciences.

[17]  Lynne S. Taylor,et al.  Effects of Polymer Type and Storage Relative Humidity on the Kinetics of Felodipine Crystallization from Amorphous Solid Dispersions , 2009, Pharmaceutical Research.

[18]  Yatindra Joshi,et al.  Phase Behavior of Amorphous Molecular Dispersions II: Role of Hydrogen Bonding in Solid Solubility and Phase Separation Kinetics , 2005, Pharmaceutical Research.

[19]  L. S. Taylor,et al.  Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. , 2009, Molecular pharmaceutics.

[20]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[21]  G. Strobl,et al.  The Physics of Polymers , 2009 .

[22]  P. Flory.  Principles of polymer chemistry , 1953 .

[23]  L. Stanciu,et al.  Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone). , 2010, Journal of pharmaceutical sciences.

[24]  Lian Yu,et al.  Solubility of Small-Molecule Crystals in Polymers: d-Mannitol in PVP, Indomethacin in PVP/VA, and Nifedipine in PVP/VA , 2009, Pharmaceutical Research.

[25]  Aibin Huang,et al.  Characteristics of konjac glucomannan and poly(acrylic acid) blend films for controlled drug release , 2006 .

[26]  Simon Bates,et al.  Evaluation of Drug-Polymer Miscibility in Amorphous Solid Dispersion Systems , 2009, Pharmaceutical Research.

[27]  T. Rades,et al.  Miscibility and interactions between 17beta-estradiol and Eudragit RS in solid dispersion. , 2008, Journal of Pharmacy and Science.

[28]  I. Sanchez,et al.  Temperature, composition and molecular-weight dependence of the binary interaction parameter of polystyrene/poly(vinyl methyl ether) blends , 1988 .